Journal of Oncology

Journal of Oncology / 2020 / Article
Special Issue

Successes and Challenges for Diagnosis and Therapy of Acute Leukemia

View this Special Issue

Corrigendum | Open Access

Volume 2020 |Article ID 1834190 | https://doi.org/10.1155/2020/1834190

Aida Vitkevičienė, Giedrė Skiauterytė, Andrius Žučenka, Mindaugas Stoškus, Eglė Gineikienė, Veronika Borutinskaitė, Laimonas Griškevičius, Rūta Navakauskienė, "Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”", Journal of Oncology, vol. 2020, Article ID 1834190, 1 page, 2020. https://doi.org/10.1155/2020/1834190

Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”

Received07 Aug 2020
Accepted07 Aug 2020
Published04 Sep 2020

In the article titled “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” [1], the last author was mistakenly linked to the second affiliation instead of the first. The corrected author list and affiliations are shown above.

References

  1. A. Vitkevičienė, G. Skiauterytė, A. Žučenka et al., “HDAC and HMT inhibitors in combination with conventional therapy: a Novel treatment option for acute promyelocytic leukemia,” Journal of Oncology, vol. 2019, Article ID 6179573, 11 pages, 2019. View at: Publisher Site | Google Scholar

Copyright © 2020 Aida Vitkevičienė et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views144
Downloads246
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.